2-nitro-N-[(Z)-[(3R,5R,8R,9S,10R,13R,14R,17R)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methylideneamino]benzamide

C30H37N3O8 — CID 93473097

About 2-nitro-N-[(Z)-[(3R,5R,8R,9S,10R,13R,14R,17R)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methylideneamino]benzamide

2-nitro-N-[(Z)-[(3R,5R,8R,9S,10R,13R,14R,17R)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methylideneamino]benzamide (PubChem CID 93473097) has the molecular formula C30H37N3O8 and a molecular weight of 567.64 g/mol. Its IUPAC name is 2-nitro-N-[(Z)-[(3R,5R,8R,9S,10R,13R,14R,17R)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methylideneamino]benzamide.

Molecular Properties

• Compound Name: 2-nitro-N-[(Z)-[(3R,5R,8R,9S,10R,13R,14R,17R)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methylideneamino]benzamide
• PubChem CID: 93473097
• Molecular Formula: C30H37N3O8
• Molecular Weight: 567.64 g/mol
• Exact Mass: 567.26
• IUPAC Name: 2-nitro-N-[(Z)-[(3R,5R,8R,9S,10R,13R,14R,17R)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methylideneamino]benzamide
• SMILES: C[C@]12CC[C@H]3[C@@H](CC[C@@]4(O)C[C@H](O)CC[C@]34/C=N\NC(=O)c3ccccc3[N+](=O)[O-])[C@]1(O)CC[C@@H]2C1=CC(=O)OC1
• InChI: InChI=1S/C30H37N3O8/c1-27-10-7-22-23(30(27,38)13-9-21(27)18-14-25(35)41-16-18)8-12-29(37)15-19(34)6-11-28(22,29)17-31-32-26(36)20-4-2-3-5-24(20)33(39)40/h2-5,14,17,19,21-23,34,37-38H,6-13,15-16H2,1H3,(H,32,36)/b31-17-/t19-,21-,22+,23-,27-,28+,29-,30-/m1/s1
• InChIKey: CPYGLZSHOFZGRI-DRUHTGNASA-N
• XLogP: 3.02
• TPSA: 171.59 Ų
• H-Bond Donors: 4
• H-Bond Acceptors: 9
• Rotatable Bonds: 5
• Heavy Atoms: 41
• Complexity: —

Lipinski Rule of Five

1 violation

Rule	Value
MW ≤ 500	567.64
LogP ≤ 5	3.02
H-Bond Donors ≤ 5	4
H-Bond Acceptors ≤ 10	9

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-nitro-N-[(Z)-[(3R,5R,8R,9S,10R,13R,14R,17R)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methylideneamino]benzamide?

The IUPAC name of 2-nitro-N-[(Z)-[(3R,5R,8R,9S,10R,13R,14R,17R)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methylideneamino]benzamide (CID 93473097) is 2-nitro-N-[(Z)-[(3R,5R,8R,9S,10R,13R,14R,17R)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methylideneamino]benzamide.

What is the SMILES notation for 2-nitro-N-[(Z)-[(3R,5R,8R,9S,10R,13R,14R,17R)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methylideneamino]benzamide?

The canonical SMILES for 2-nitro-N-[(Z)-[(3R,5R,8R,9S,10R,13R,14R,17R)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methylideneamino]benzamide is C[C@]12CC[C@H]3[C@@H](CC[C@@]4(O)C[C@H](O)CC[C@]34/C=N\NC(=O)c3ccccc3[N+](=O)[O-])[C@]1(O)CC[C@@H]2C1=CC(=O)OC1.

What is the InChIKey of 2-nitro-N-[(Z)-[(3R,5R,8R,9S,10R,13R,14R,17R)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methylideneamino]benzamide?

The InChIKey is CPYGLZSHOFZGRI-DRUHTGNASA-N. The full InChI is InChI=1S/C30H37N3O8/c1-27-10-7-22-23(30(27,38)13-9-21(27)18-14-25(35)41-16-18)8-12-29(37)15-19(34)6-11-28(22,29)17-31-32-26(36)20-4-2-3-5-24(20)33(39)40/h2-5,14,17,19,21-23,34,37-38H,6-13,15-16H2,1H3,(H,32,36)/b31-17-/t19-,21-,22+,23-,27-,28+,29-,30-/m1/s1.

What are the key properties of 2-nitro-N-[(Z)-[(3R,5R,8R,9S,10R,13R,14R,17R)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methylideneamino]benzamide?

2-nitro-N-[(Z)-[(3R,5R,8R,9S,10R,13R,14R,17R)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methylideneamino]benzamide has a molecular weight of 567.64 g/mol, XLogP of 3.02, 5 rotatable bonds, 4 hydrogen bond donors, and 9 hydrogen bond acceptors.

Where does this data come from?

All data for 2-nitro-N-[(Z)-[(3R,5R,8R,9S,10R,13R,14R,17R)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methylideneamino]benzamide is sourced from PubChem (CID 93473097), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).